Hidrops fetal por infección congénita por citomegalovirus: tratamiento posneonatal prolongado con valganciclovir

Hidrops fetal por infección congénita por citomegalovirus: tratamiento posneonatal prolongado con valganciclovir

El citomegalovirus (CMV) es la infección viral congénita más frecuente con una prevalencia de 0,5% al nacimiento. La primoinfección aparece entre el 1-4% de las gestantes seronegativas. El 40% de estos fetos se infectan y un 10% presentan síntomas al nacimiento. Presentamos un caso de infección cong...

Full description

Bibliographic Details
Main Authors:	Silvia Campos Arca, María Fernández Rial, Isabel Pardo Pumar, Cristina Luaces, José García Piñó, Eloy Moral Santamarina
Format:	Article
Language:	English
Published:	Permanyer 2012-01-01
Series:	Revista Chilena de Obstetricia y Ginecología
Subjects:	Infección congénita citomegalovirus congénito ganciclovir valganciclovir Congenital infection congenital cytomegalovirus
Online Access:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-75262012000100009

Similar Items

Refractory ulcerative colitis complicated by cytomegalovirus infection successfully treated with valganciclovir
by: Tiziana Larussa, et al.
Published: (2012-11-01)

Treatment of congenital cytomegalovirus infection
by: Gyu Hong Shim
Published: (2023-09-01)

Valganciclovir—Ganciclovir Use and Systematic Therapeutic Drug Monitoring. An Invitation to Antiviral Stewardship
by: Alicia Galar, et al.
Published: (2021-01-01)

Congenital cytomegaly infection - current reports on prevention, diagnosis and effective therapy
by: Monika Wacławska, et al.
Published: (2022-05-01)

Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant Centers
by: Cornelius Engelmann, et al.
Published: (2020-07-01)

Establishment and Evaluation of a Parametric Population Pharmacokinetic Model Repository for Ganciclovir and Valganciclovir
by: Wenyu Yang, et al.
Published: (2023-06-01)

Oral Administration of Valganciclovir Reduces Clinical Signs, Virus Shedding and Cell-Associated Viremia in Ponies Experimentally Infected with the Equid Herpesvirus-1 C<sub>2254</sub> Variant
by: Côme J. Thieulent, et al.
Published: (2022-05-01)

Cytomegalovirus Retinitis in a Patient with Large Cell Diffuse Non-Hodgkin’s Lymphoma
by: Ali Kal
Published: (2021-08-01)

Successful treatment of cytomegalovirus pneumonia in a child on maintenance chemotherapy for acute lymphoblastic leukemia without the use of intravenous immunoglobulin
by: Sidharth Totadri, MD, DM, et al.
Published: (2017-03-01)

Detection of antiviral drug resistance in patients with congenital cytomegalovirus infection using long-read sequencing: a retrospective observational study
by: Yuka Torii, et al.
Published: (2022-06-01)

ESTUDO DA INCIDÊNCIA DE INFECÇÃO ATIVA POR CITOMEGALOVÍRUS EM TRANSPLANTE PULMONAR E PROFILAXIA UNIVERSAL COM GANCICLOVIR INTRAVENOSO
by: Regina Barbosa Schröeder, et al.
Published: (2005-03-01)

Fifteen-Year Surveillance of LTR Receiving Pre-Emptive Therapy for CMV Infection: Prevention of CMV Disease and Incidence of CLAD
by: Davide Piloni, et al.
Published: (2022-11-01)

A UHPLC–MS/MS Method for Therapeutic Drug Monitoring of Aciclovir and Ganciclovir in Plasma and Dried Plasma Spots
by: Federica Pigliasco, et al.
Published: (2021-10-01)

Cytomegalovirus mismatch after heart transplantation: Impact of antiviral prophylaxis and intravenous hyperimmune globulin
by: Moritz B. Immohr, et al.
Published: (2021-12-01)

Infección por citomegalovirus en pacientes con injerto renal
by: Gerardo Borroto Díaz, et al.
Published: (2003-08-01)

Correlation of cytomegalovirus viral load between whole blood and plasma of congenital cytomegalovirus infection under valganciclovir treatment
by: Yuka Torii, et al.
Published: (2023-01-01)

Efficacy of Low Dose Valganciclovir Prophylaxis for Cytomegalovirus Infection in Kidney Transplantation
by: Ümit Özçelik, et al.
Published: (2020-01-01)

Valganciclovir as Add-On to Standard Therapy in Secondary Glioblastoma
by: Giuseppe Stragliotto, et al.
Published: (2020-09-01)

Diagnóstico tardio de Citomegalovirose em recém-nascido pré-termo, por carência de triagem no período gestacional: uma realidade do Brasil - Relato de Caso
by: Ana Paula Morguete Ferreira, et al.
Published: (2018-10-01)

Efficacy and Safety of Antiviral Agents in Preventing Allograft Rejection Following CMV Prophylaxis in High-Risk Kidney Transplantation: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
by: Narisa Ruenroengbun, et al.
Published: (2022-04-01)

Different clinical manifestations in two siblings with cytomegalovirus infection
by: L. Álvarez-Hernández, et al.
Published: (2017-07-01)

Efficacy and safety of universal valganciclovir prophylaxis combined with a tacrolimus/mycophenolate-based regimen in kidney transplantation
by: O Manuel, et al.
Published: (2007-12-01)

Valganciclovir as Add-on to Second-Line Therapy in Patients with Recurrent Glioblastoma
by: Mattia Russel Pantalone, et al.
Published: (2022-04-01)

Letermovir for Cytomegalovirus Prophylaxis in Lung Transplant Patients with Valganciclovir-Induced Leukopenia
by: Arindam Singha, et al.
Published: (2021-04-01)

Role of Valganciclovir in Children with Congenital CMV Infection: A Review of the Literature
by: Davide Pata, et al.
Published: (2023-07-01)

Role of oral valganciclovir in sick preterm with cytomegalovirus virus infection and ventilation dependence
by: Anumodan Gupta, et al.
Published: (2019-01-01)

Efficacy of valganciclovir and ganciclovir for cytomegalovirus disease in solid organ transplants: A meta-analysis
by: Siavash Vaziri, et al.
Published: (2014-01-01)

Cardiogenic shock due to citomegalovirus myocarditis: successful clinical treatment Choque cardiogênico devido à miocardite por citomegalovírus: terapêutica clínica com sucesso
by: José Francisco Baumgratz, et al.
Published: (2010-06-01)

Infección congénita por citomegalovirus: presentación de tres casos y revisión de la literatura
by: Carlos Eduardo Fonseca-Becerra, et al.
Published: (2012-06-01)

Application of redox reactions for the determination of valganciclovir hydrochloride in pharmaceuticals
by: Nagib Abdullah Salem Qarah, et al.
Published: (2020-03-01)

Development of an appropriate simple suspension method for valganciclovir medication
by: Yasuyuki Masaoka, et al.
Published: (2020-07-01)

Less renal allograft fibrosis with valganciclovir prophylaxis for cytomegalovirus compared to high-dose valacyclovir: a parallel group, open-label, randomized controlled trial
by: Tomas Reischig, et al.
Published: (2018-11-01)

INFECCIÓN CONGÉNITA POR CITOMEGALOVIRUS: NUEVOS ASPECTOS TERAPÉUTICOS
by: Marcelo Rodríguez G, et al.
Published: (2008-01-01)

Infección congénita por citomegalovirus: presentación de tres casos y revisión de la literatura Congenital cytomegalovirus infection: a presentation of three cases and a literature review
by: Carlos Eduardo Fonseca-Becerra, et al.
Published: (2012-06-01)

Efficacy of short term valganciclovir in a standard-dose for cytomegalovirus prophylaxis in living donor kidney transplantation: a single-center report
by: Gokhan Ertugrul, et al.
Published: (2019-09-01)

Valganciclovir is not associated with decreased EBV infection rate in pediatric kidney transplantation
by: Elodie Cheyssac, et al.
Published: (2023-01-01)

Prevalência de infecção congênita por citomegalovírus em recém-nascidos de uma unidade de tratamento intensivo de um hospital público The prevalence of congenital cytomegalovirus infection in newborn infants at an intensive care unit in a public hospital
by: Clarissa Schreiner Miura, et al.
Published: (2006-02-01)

Cytomegalic hepatitis in a patient receiving omalizumab
by: R. Gonçalves, et al.
Published: (2016-01-01)

Presumed cytomegalovirus retinitis in a non-immune compromised patient with breast carcinoma during treatment: A case report
by: Chia-Chen Kao, et al.
Published: (2021-09-01)

Hemorragia cerebrovascular asociada con infección por citomegalovirus en un lactante menor
by: Nelson Muñoz, et al.
Published: (2014-12-01)